Jubilant Ingrevia Share Price Target 2027: Base and Bull Targets Built on FY26 Earnings

Investors weighing a Jubilant Ingrevia target price for 2027 should start with where the stock sits today. At Rs 621.50 on 9 October 2026, it is 21.8% below its 52-week high of Rs 795.00 and 15.7% above its 52-week low of Rs 537.30. That range spans 48% from low to high, so the entry point matters as much as the Jubilant Ingrevia price forecast itself.

This article builds the Jubilant Ingrevia share price target from reported numbers only: five years of annual results, the last five quarters, the latest shareholding pattern and current valuation ratios from company filings and exchange data. Each scenario shows its assumptions, so you can see exactly how the Rs 745 base case and the Rs 892 bull case were reached, along with a downside risk level of Rs 497.

Click Here – Get Free Investment Predictions

Jubilant Ingrevia Stock Analysis: Company Overview and Key Stats

Jubilant Ingrevia (NSE: JUBLINGREA) has a market capitalisation of Rs 9,887 crore. In FY26 it reported revenue of Rs 4,429 crore and net profit of Rs 277.90 crore. The table collects the figures the Jubilant Ingrevia share price target is built on.

Metric	Value
Company	Jubilant Ingrevia
NSE Ticker	JUBLINGREA
CMP (9 October 2026)	Rs 621.50
52-Week High	Rs 795.00
52-Week Low	Rs 537.30
Market Cap	Rs 9,887 crore
PE Ratio (TTM)	32.03
Industry PE	36.60
Price to Book	3.08
Return on Equity	8.89%
Debt to Equity	0.25
EPS (TTM)	Rs 19.38
Dividend Yield	0.81%
12-Month Base Target	Rs 745
Bull Case	Rs 892
Downside Risk Level (not a target)	Rs 497

Why Is Jubilant Ingrevia Share Price Target Set at Rs 745 for 2027?

The base-case Jubilant Ingrevia stock target of Rs 745 applies a PE multiple of 32.03 to a forward EPS estimate of Rs 23.26. That EPS assumes 20.0% yearly growth, the pace from FY24 to FY26, and puts the target 19.9% above the current price. The bull case adds faster earnings growth and a higher multiple, while the downside risk level assumes flat earnings and a lower multiple.

Earnings Growth Behind the Jubilant Ingrevia Target Price: Five Years of Results

Jubilant Ingrevia grew revenue from Rs 4,981 crore in FY22 to Rs 4,429 crore in FY26, a compound annual growth rate of -2.9%. Net profit grew more slowly, from Rs 476.71 crore to Rs 277.90 crore (-12.6% a year), which points to margin pressure alongside the sales growth.

Financial Year	Revenue (Rs Cr)	Net Profit (Rs Cr)	EPS (Rs)	Dividend per Share (Rs)
FY22	4,980.85	476.71	29.97	5.00
FY23	4,806.06	307.50	19.33	5.00
FY24	4,171.10	182.89	11.55	5.00
FY25	4,215.43	251.18	15.84	5.00
FY26	4,428.60	277.90	17.51	5.00

FY26 revenue growth was 5.1%, faster than the four-year average of -2.9%, and net profit moved up 10.6%. EPS rose from Rs 11.55 in FY24 to Rs 17.51 in FY26. The FY27 outlook depends on whether that EPS estimate keeps compounding.

Margins and the Latest Quarter

Jubilant Ingrevia converted 6.3% of FY26 revenue into net profit, against 6.0% in FY25, within a five-year range of 4.4% to 9.6%. EBITDA margin was 13.4% in FY26 versus 13.2% in FY25.

In the June 2026 quarter, revenue was Rs 1,310 crore, up 24.9% from the same quarter a year earlier, while net profit of Rs 105.82 crore was up 40.9%. EBITDA came in at Rs 209.33 crore, up 36.5% year on year. The next quarterly result is the first test of whether the earnings assumption holds.

Balance Sheet and Cash Flow

Debt to equity stands at 0.25, and shareholders' equity grew from Rs 2,433 crore in FY22 to Rs 3,126 crore in FY26. Operating cash flow in FY26 was Rs 524.27 crore against capital expenditure of Rs 299.36 crore, leaving free cash flow of Rs 224.91 crore, or 2.3% of the current market capitalisation. In FY25 free cash flow was Rs 142.31 crore.

Valuation Check for the Jubilant Ingrevia Stock Target: PE, Price to Book and ROE

At a PE of 32.03 against an industry PE of 36.60, Jubilant Ingrevia trades at a discount to its industry. Price to book is 3.08 on a book value of Rs 201.38 per share, and return on equity is 8.89%. A PE of 32.03 equals an earnings yield of 3.1%, and the FY26 dividend of Rs 5.00 per share gives a yield of 0.81%.

Shareholding Pattern and Institutional Holding

Promoters held 45.22% of Jubilant Ingrevia in June 2026, and promoter holding has stayed near 45.22% since June 2025. Foreign institutional investors (FII) held 6.49% and domestic institutions (DII) held 24.98%, which puts total institutional holding at 31.47%. FII holding fell from 6.96% in June 2025 to 6.49% in June 2026. Public shareholders own the remaining 23.30%. A meaningful institutional holding adds a layer of research coverage and trading depth.

Jubilant Ingrevia Share Price Targets for the Short Term and 12 Months

Short Term Jubilant Ingrevia Stock Target Levels: Technical Setup

At Rs 621.50 on 9 October 2026, Jubilant Ingrevia trades below its 50-day simple moving average of Rs 684.00 and below its 200-day exponential moving average of Rs 677.81. The 14-day RSI reads 48.9, which is neutral territory, and the MACD line sits above its signal line. The nearest resistance level is Rs 677.81 (200-day exponential moving average) and the nearest support is Rs 537.30 (52-week low). A sustained move above Rs 677.81 would improve the short-term setup, while a close below Rs 537.30 would shift attention to the next support.

12 Month Jubilant Ingrevia Target Price for 2027

The 12-month target for Jubilant Ingrevia is Rs 745: forward EPS of Rs 23.26 at a PE of 32.03. That is 19.9% above Rs 621.50. It would still leave the stock 6.3% below its 52-week high of Rs 795.00.

How EPS Growth and PE Multiple Change the Jubilant Ingrevia Target Price

EPS Growth	PE 25.62	PE 32.03	PE 36.83
0.0% (EPS Rs 19.38)	Rs 497	Rs 621	Rs 714
20.0% (EPS Rs 23.26)	Rs 596	Rs 745	Rs 857
25.0% (EPS Rs 24.22)	Rs 621	Rs 776	Rs 892

Each cell multiplies the forward EPS estimate by the PE shown. Reading across a row shows what a de-rating or re-rating does to the Jubilant Ingrevia price forecast, and reading down a column shows what earnings growth is worth at a fixed multiple.

Bull Case and Downside Risk for Jubilant Ingrevia Stock Target in 2027

Bull Case Rs 892

The bull case Jubilant Ingrevia price target needs EPS growth of 25.0%, which lifts forward EPS to Rs 24.22, and a PE multiple that rises 15% to 36.83. That gives Rs 892, 43.5% above the current price and above the 52-week high of Rs 795.00, so the stock would have to set a fresh 52-week high.

Downside Risk Level Rs 497

The downside risk level is not a target. It assumes EPS stays flat at Rs 19.38 and the PE falls 20% to 25.62. That gives Rs 497, 20.0% below the current price and below the 52-week low of Rs 537.30.

Scenario	EPS Growth	PE Multiple	Price (Rs)	Change vs CMP
Bull Case	25.0%	36.83	Rs 892	+43.5%
Base Case	20.0%	32.03	Rs 745	+19.9%
Downside Risk	0.0%	25.62	Rs 497	-20.0%

Key Risks to the Jubilant Ingrevia Target Price for 2027

Growth Slowdown Risk for the Jubilant Ingrevia Price Target

Revenue in the June 2026 quarter was up 24.9% year on year, and FY26 revenue growth was 5.1%. If growth slows from here, the EPS estimate behind the Jubilant Ingrevia stock target will need revising.

Liquidity and Size Risk

Jubilant Ingrevia has a market capitalisation of Rs 9,887 crore. Institutional holding is 31.47%, and promoters hold 45.22%. Stocks of this size can move sharply on small volumes, and exits can take longer than entries.

Valuation and Margin Risk

Net margin was 6.3% in FY26, so a small slip in costs moves profit noticeably. At a PE of 32.03 versus an industry PE of 36.60, a de-rating toward the downside-risk PE of 25.62 would cut the price even if earnings hold.

Market and Technical Risk

The stock trades 21.8% below its 52-week high, with an RSI of 48.9 and a MACD reading above its signal line. Broader market weakness can override company fundamentals in the short term.

How to Invest in Jubilant Ingrevia

Start with the live price and volume. Any Jubilant Ingrevia share price target is only as current as the data behind it, and the data here is as of 9 October 2026, so refresh the Rs 621.50 price before acting on any level.

Next, review the fundamentals yourself. The Univest Screener lets you check Jubilant Ingrevia's PE, ROE, debt and shareholding in one place.

Check Jubilant Ingrevia fundamentals on the Univest Screener

Then compare the three Jubilant Ingrevia target price scenarios with your own view. If you expect EPS growth below 20.0%, the base case is too optimistic for you; if you expect more, the bull case deserves weight.

Decide your position size and exit levels before you buy. The support and resistance levels above can serve as reference points, but they are not recommendations.

Finally, place the order through a SEBI-registered broker or the Univest app, and review the position after each quarterly result. Consult a SEBI-registered advisor if you are unsure.

Download the Univest iOS App or Univest Android App to track Jubilant Ingrevia live price and get daily stock recommendations.

Conclusion

The Jubilant Ingrevia share price target for 2027 is Rs 745 in the base case, with Rs 892 as the bull case. The support for that view is arithmetic you can check: EPS grew 23.1% a year over FY24 to FY26, and the stock trades at a PE of 32.03. The risks are equally concrete, including a stock that sits 21.8% below its 52-week high and a downside scenario that cuts the price 20% if earnings stall. Use these numbers as a framework, check them against the latest filings, and size any position to your own risk appetite.

FAQs on Jubilant Ingrevia Share Price Target 2027

What is the Jubilant Ingrevia share price target for 2027?

Ans. The base-case Jubilant Ingrevia share price target for 2027 is Rs 745, with Rs 892 as the bull case. The downside risk level, which is not a target, is Rs 497. These are model estimates from reported earnings and the current PE, not guaranteed outcomes.

What is the Jubilant Ingrevia share price today?

Ans. As of 9 October 2026, 3:29 PM IST, Jubilant Ingrevia trades at Rs 621.50, up 0.19% on the day. The 52-week range is Rs 537.30 to Rs 795.00.

Is Jubilant Ingrevia a buy or sell at the current price?

Ans. The data is mixed rather than one-sided: EPS has grown 23.1% a year over FY24 to FY26, but the stock is 21.8% below its 52-week high. Whether Jubilant Ingrevia fits your portfolio depends on your time horizon and risk appetite, so consult a SEBI-registered advisor before investing. This article is not investment advice.

What are the bull case target and downside risk level for Jubilant Ingrevia shares?

Ans. The bull case target is Rs 892, which assumes 25.0% EPS growth and a PE of 36.83. The downside risk level is Rs 497, which assumes flat EPS and a PE of 25.62. It marks a risk, not a target.

What are the main risks to the Jubilant Ingrevia price target?

Ans. The main risks are slower revenue growth, a small market capitalisation of Rs 9,887 crore, a PE de-rating and short-term weakness in the broader market. Each is covered in the risk section above.

What is the PE ratio of Jubilant Ingrevia and how does it compare with the industry?

Ans. The PE ratio of Jubilant Ingrevia is 32.03 against an industry PE of 36.60. Price to book is 3.08 and return on equity is 8.89%. The base case in the Jubilant Ingrevia price target holds this PE constant.

Who owns Jubilant Ingrevia, and what is the promoter holding?

Ans. Promoters held 45.22% of Jubilant Ingrevia in June 2026. FII held 6.49%, DII held 24.98% and the public held 23.30%.

What were Jubilant Ingrevia's latest quarterly results?

Ans. In the June 2026 quarter, Jubilant Ingrevia reported revenue of Rs 1,310 crore (up 24.9% year on year) and net profit of Rs 105.82 crore (up 40.9%).